[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPS5817465B2 - Method for producing tetrahydroisoquinoline derivatives - Google Patents

Method for producing tetrahydroisoquinoline derivatives

Info

Publication number
JPS5817465B2
JPS5817465B2 JP52106200A JP10620077A JPS5817465B2 JP S5817465 B2 JPS5817465 B2 JP S5817465B2 JP 52106200 A JP52106200 A JP 52106200A JP 10620077 A JP10620077 A JP 10620077A JP S5817465 B2 JPS5817465 B2 JP S5817465B2
Authority
JP
Japan
Prior art keywords
reaction
compound
mixture
trimethoxybenzyl
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP52106200A
Other languages
Japanese (ja)
Other versions
JPS5452070A (en
Inventor
岩隈建男
山田幸一郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Priority to JP52106200A priority Critical patent/JPS5817465B2/en
Publication of JPS5452070A publication Critical patent/JPS5452070A/en
Publication of JPS5817465B2 publication Critical patent/JPS5817465B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Other In-Based Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】 本発明は5,7−シヒドロキシー1−(3,4゜5−ト
リメトキシベンジル)−1,2,3,4−テトラヒドロ
イソキノリンの新規製法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a new process for the preparation of 5,7-cyhydroxy-1-(3,4°5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline.

本発明の目的化合物である5、7−シヒドロキシー1−
1 (g 、 4、5−)リメトキシベンジル)−1,
2,3,4−テトラヒトロインキノリン(L)服すぐれ
た気管支拡張作用及び強い血流増加作用を有する有用な
医薬化合物であることが知られている(特開昭51−7
0770号)。
5,7-hydroxyl-1- which is the object compound of the present invention
1 (g, 4, 5-)rimethoxybenzyl)-1,
2,3,4-Tetrahytroinquinoline (L) is known to be a useful medicinal compound with excellent bronchodilatory effect and strong blood flow increasing effect (Japanese Patent Application Laid-Open No. 1986-7
No. 0770).

しかし、この化合物CI)はイソキノリン骨格の6位に
電子供与性置換基を有さないため、その製造には数多く
の工程より成る迂遠なルートを経由する必要があり、工
業的製法としてはより簡便な製造が望まれる。
However, since this compound CI) does not have an electron-donating substituent at the 6-position of the isoquinoline skeleton, its production requires a circuitous route consisting of many steps, making it a simpler industrial method. Manufacturing is desired.

本発明者等は、化合物CI)の簡易合成法を探求し研究
を重ねた結果、パルビニル(Barbier )反応を
利用すれば、工程数を短縮することができ、かつ収率よ
く化合物CI) を製造しうろことを見出した。
As a result of repeated research and search for a simple synthesis method for compound CI), the present inventors found that by using the Barbier reaction, the number of steps can be shortened and compound CI) can be produced with high yield. I found Shiroko.

本発明によれば、目的化合物CI)は下記反応式で示さ
れる方法によシ容易に製造される。
According to the present invention, the target compound CI) can be easily produced by the method shown in the following reaction formula.

(但し、R1及びR2はベンジル基、R3は3゜4.5
−)リメトキシベンジル基、X及びX′はハロゲン原子
を表わす) 即ち、インキノリニウム塩(I[’3、マグネシウムお
よび3,4.5−)リメトキシベンジルハライドをパル
ビニル反応に付し、得られる1、2−ジヒドロイソキノ
リン誘導体(EV)の3位4位間ノ、=重結合tr:ソ
ジウムモノアセトキシボロヒドリドにて単結合に還元し
て1,2.3.4−テトラヒドロイソキノリン誘導体〔
■〕を得、次いでこの化合物を接触還元反応に付すこと
によシ目的化合物CI)を得ることができる。
(However, R1 and R2 are benzyl groups, R3 is 3°4.5
-)rimethoxybenzyl group; The = heavy bond tr between the 3- and 4-positions of the 1,2-dihydroisoquinoline derivative (EV) is reduced to a single bond with sodium monoacetoxyborohydride to produce the 1,2,3,4-tetrahydroisoquinoline derivative [
(2)] and then subjecting this compound to a catalytic reduction reaction to obtain the desired compound CI).

以下、本発明方法を詳しく説明する。The method of the present invention will be explained in detail below.

第一工程のパルビニル反応は、適当な溶媒中においてイ
ンキノリニウム塩(II)及びマグネシウム片の混合物
に3、4、5−4リメトキ7ベンジルハライドを加え、
混液中に生成する3、4,5−トリメトキ7ベンジルマ
グネシウムハライド(III)を直ちにインキノリニウ
ム塩(I[)と反応させることによシ実施することがで
きる。
The first step, the parvinyl reaction, involves adding 3,4,5-4rimethoxy7benzyl halide to a mixture of inquinolinium salt (II) and magnesium pieces in a suitable solvent;
This can be carried out by immediately reacting the 3,4,5-trimethoxy7benzylmagnesium halide (III) formed in the mixed solution with the inquinolinium salt (I[).

原料インキノリニウム塩(n)としては、例えば記号X
で示される基が塩素、臭素等である化合物を有利に使用
できる。
As the raw material ink quinolinium salt (n), for example, symbol X
Compounds in which the group represented by is chlorine, bromine, etc. can be advantageously used.

また、反応が生起しにくい場合には、たとえば1,2−
ジブロモエタンの如き反応開始剤を少量使用して反応を
生起嘔せることもできる。
In addition, if the reaction is difficult to occur, for example, 1,2-
The reaction can also be initiated using small amounts of initiators such as dibromoethane.

一般に反応は熱時にスムースに進行し、高収率にて1,
2−ジヒドロイソキノリン誘導体(IV)を得ることが
できる。
In general, the reaction proceeds smoothly when heated, with a high yield of 1,
A 2-dihydroisoquinoline derivative (IV) can be obtained.

ここに得られる化合物(IV)は不安定であるので、単
離することなく゛次工程の原料とするのが好都合である
Since the compound (IV) obtained here is unstable, it is convenient to use it as a raw material for the next step without isolation.

第二工程の還元反応は、ソジウムモノアセトキンボロヒ
ドリドを還元試薬として用いて実施するこの還元試薬は
、試薬そのものを反応液に添加してもよく、また、反応
液にソジウムボロヒドリドと酢酸を別々に加えて反応の
場合で生成した試薬を利用してもよい。
The reduction reaction in the second step is carried out using sodium monoacetoquine borohydride as a reducing reagent.The reagent itself may be added to the reaction solution, or sodium borohydride may be added to the reaction solution. It is also possible to utilize the reagent generated in the case of reaction by adding acetic acid separately.

反応は、たとえば適当な溶媒中で1,2−ジヒドロイソ
キノリン誘導体(IV)と還元試薬とを反応させれば、
熱時好適に還元反応が進行し、収率よくテトラヒドロイ
ソキノリン誘導体〔■〕を得ることができる。
The reaction can be carried out, for example, by reacting the 1,2-dihydroisoquinoline derivative (IV) with a reducing reagent in a suitable solvent.
The reduction reaction progresses suitably when heated, and the tetrahydroisoquinoline derivative [■] can be obtained in good yield.

第三工程の接触還元反応は常法に従い適当な溶媒中接触
還元触媒の存在下に化合物(V)と水素ガスとを接触さ
せることにより実施できる。
The catalytic reduction reaction in the third step can be carried out by bringing the compound (V) into contact with hydrogen gas in a suitable solvent in the presence of a catalytic reduction catalyst according to a conventional method.

前記触媒としては例えば、酸化白金、パラジウム・カー
ボン等を使用できる。
As the catalyst, for example, platinum oxide, palladium/carbon, etc. can be used.

反応は常温常圧乃至加温加圧下にてもスムースに進行し
、高収率にて目的化合物〔■を得ることができる。
The reaction proceeds smoothly even under normal temperature and normal pressure to heat and pressure, and the target compound [■] can be obtained in high yield.

以上詳しく説明した如く、本発明方法は、たとえば前記
特開昭51−70770号に記載された目的化合物〔I
〕の製法(ライセルト反応を利用した方法)に比べ、工
程数も3工程減少し、(5゜7−ジ置換インキノリン(
Vl)を基準とする)。
As explained in detail above, the method of the present invention is applicable to the target compound [I
] The number of steps is reduced by 3 compared to the production method (method using the Lysselt reaction), and
(based on Vl).

また、収率も約37%程向−ヒしており(前記と同一基
準)、目的化合物CI)の製法として優れた方法である
Furthermore, the yield was about 37% higher (same standard as above), making it an excellent method for producing the target compound CI).

尚、本発明の原料化合物(II)はたとえば5゜7−ジ
置換インキノリン(Vl)よシ下記反応式で示される方
法によシ製しうる。
The starting compound (II) of the present invention can be prepared, for example, from 5°7-disubstituted inquinoline (Vl) by the method shown in the following reaction formula.

(但し、R1,R2及びXは前記と同一意味を有する) 実施例 (1)マグネシウム片5gをテトラヒドロフラン(以下
、THFと称す)150mlにけん濁し、窒素気流下に
1,2−ジブロモエタン0.9 rul ヲ加え、室温
で15分かくはんする。
(However, R1, R2, and X have the same meanings as above.) Example (1) 5 g of magnesium pieces were suspended in 150 ml of tetrahydrofuran (hereinafter referred to as THF), and 0.5 g of 1,2-dibromoethane was added under a nitrogen stream. Add 9 ml and stir at room temperature for 15 minutes.

これに、2−ベンジル−5,7−ジベンジルオキシイソ
キノリニウムプロミド15.0gを加え、次いで34.
5−トリメトキシベンジルクロリド10gのTHF80
ml溶液を10分で滴下し、室温で15分かくはん後、
45分間還流する。
To this was added 15.0 g of 2-benzyl-5,7-dibenzyloxyisoquinolinium bromide, and then 34.
5-trimethoxybenzyl chloride 10g THF80
ml solution was added dropwise over 10 minutes, and after stirring at room temperature for 15 minutes,
Reflux for 45 minutes.

今後、反応液よシネ溶物をろ去して、2−ベンジル−5
,7−ジペンジルオキシー1−(3,4,5−トリメト
キシベンジル)−1,2−ジヒドロイソキノリン(7)
THF溶液を得る。
From now on, filter off the cine solution from the reaction solution, and remove the 2-benzyl-5
,7-dipenzyloxy-1-(3,4,5-trimethoxybenzyl)-1,2-dihydroisoquinoline (7)
Obtain a THF solution.

(2) (1)で得たTHF溶液にソジウムボロヒド
リド11、:lを加え、次いで水冷下に酢酸18gを滴
下する。
(2) Add 11:1 of sodium borohydride to the THF solution obtained in (1), and then add 18 g of acetic acid dropwise while cooling with water.

反応液を室温で30分かくはん後、3.5時間還流する
The reaction solution was stirred at room temperature for 30 minutes and then refluxed for 3.5 hours.

反応液を減圧濃縮し、残置に氷水を加え、クロロホルム
で抽出する。
The reaction solution was concentrated under reduced pressure, ice water was added to the residue, and the mixture was extracted with chloroform.

抽出層を水洗、乾燥後溶媒を留去し、残置の黄色油状物
をメタノール・エーテル混液にとかし、そこへ塩化水素
を含むエーテルを加え、一夜放置する。
After washing the extracted layer with water and drying, the solvent is distilled off. The remaining yellow oil is dissolved in a methanol/ether mixture, ether containing hydrogen chloride is added thereto, and the mixture is left overnight.

析出結晶をろ取すれば、2−ベンジル−5,7−ジペン
ジルオキシー1−(3,4゜5−トリメトキシベンジル
)−1,2,3,4−テトラヒドロイソキノリン塩酸塩
を無色プリズム晶として16.:l得る。
If the precipitated crystals are filtered, 2-benzyl-5,7-dipenzyloxy-1-(3,4゜5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride can be obtained as colorless prism crystals. As 16. :l get.

mp、127〜130°C(分解)、収率92% 本旨はメタノール・エーテル混液よシ再結晶すれば1m
p、132〜136℃(分解)を示す。
mp, 127-130°C (decomposition), yield 92% The main idea is that if recrystallized from a methanol/ether mixture, 1 m
p, 132-136°C (decomposed).

(3)本旨132.3g、10%パラジウム・カーボン
25g、10%塩酸150TrLl、メタノール125
0m1及び水100m1の混液を、室温下、水素気流中
(3〜4気圧)でしんとうして接触還元を行う(約5時
間を要す)。
(3) Main substance 132.3g, 10% palladium/carbon 25g, 10% hydrochloric acid 150TrLl, methanol 125g
Catalytic reduction is performed by cooling a mixture of 0 ml and 100 ml of water at room temperature in a hydrogen stream (3 to 4 atm) (requires about 5 hours).

反応終了後、触媒をろ去し、ろ液より溶媒を留去し、残
置をメタノール・エーテル混液で結晶化させ、ろ取すれ
ば、5,7−シヒドロキシー1−(3,45−トリメト
キシベンジル)−1,2,3,4−テトラヒドロイソキ
ノリン塩酸塩を無色結晶として66、L9得る。
After the reaction is complete, the catalyst is filtered off, the solvent is distilled off from the filtrate, and the residue is crystallized from a methanol/ether mixture and collected by filtration to give 5,7-hydroxy-1-(3,45-trimethoxybenzyl )-1,2,3,4-tetrahydroisoquinoline hydrochloride is obtained as colorless crystals of 66, L9.

収率87.5%。本旨はエタノール・イソプロピルエー
テル混液から再結晶すれば、無色針状晶にして、m92
40〜243°C(分解)を示す。
Yield 87.5%. The main idea is that if recrystallized from a mixture of ethanol and isopropyl ether, it will become colorless needle crystals with m92
40-243°C (decomposition).

Claims (1)

【特許請求の範囲】 1 一般式 (但し、R1及びR2はベンジル基を表わし、Xは・・
ロゲン原子を表わす) で示されるインキノリニウム塩とマグネシウムとの混合
物に3.4.5−トリメトキシベンジルハライドを加え
て反応させ、一般式 (但し、R1及びR2は前記と同一意味を櫓する)で示
される1、2−ジヒドロイソキノリン誘導体を得、この
化合物の3位4位間の二重結合をソジウムモノアセトキ
シボロヒドリドにて単結合に還元し、得られる一般式 (但し、旦1及びR2は前記と同一意味を有する)で示
されるi、2,3.4−テトラヒドロイソキノリン誘導
体を接触還元反応に付することを特徴とする5、7−シ
ヒドロキシー1−(3,4,5−トリメトキシベンジル
)−1,2,3,4−テトラヒドロイソキノリンの製法
[Claims] 1 General formula (wherein R1 and R2 represent a benzyl group, and X is...
3.4.5-trimethoxybenzyl halide is added to a mixture of an inquinolinium salt represented by the formula (representing a halogen atom) and magnesium, and the mixture is reacted with the general formula (where R1 and R2 have the same meanings as above). ) is obtained, and the double bond between the 3rd and 4th positions of this compound is reduced to a single bond with sodium monoacetoxyborohydride. 5,7-hydroxy-1-(3,4,5- Method for producing (trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline.
JP52106200A 1977-09-02 1977-09-02 Method for producing tetrahydroisoquinoline derivatives Expired JPS5817465B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP52106200A JPS5817465B2 (en) 1977-09-02 1977-09-02 Method for producing tetrahydroisoquinoline derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52106200A JPS5817465B2 (en) 1977-09-02 1977-09-02 Method for producing tetrahydroisoquinoline derivatives

Publications (2)

Publication Number Publication Date
JPS5452070A JPS5452070A (en) 1979-04-24
JPS5817465B2 true JPS5817465B2 (en) 1983-04-07

Family

ID=14427515

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52106200A Expired JPS5817465B2 (en) 1977-09-02 1977-09-02 Method for producing tetrahydroisoquinoline derivatives

Country Status (1)

Country Link
JP (1) JPS5817465B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0545170U (en) * 1991-11-25 1993-06-18 株式会社東海理化電機製作所 Key cylinder device

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5170770A (en) * 1974-11-20 1976-06-18 Tanabe Seiyaku Co
JPS5170771A (en) * 1974-11-25 1976-06-18 Tanabe Seiyaku Co TETORAHIDOROISOKINORIN JUDOTAINO SEIHO

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5170770A (en) * 1974-11-20 1976-06-18 Tanabe Seiyaku Co
JPS5170771A (en) * 1974-11-25 1976-06-18 Tanabe Seiyaku Co TETORAHIDOROISOKINORIN JUDOTAINO SEIHO

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0545170U (en) * 1991-11-25 1993-06-18 株式会社東海理化電機製作所 Key cylinder device

Also Published As

Publication number Publication date
JPS5452070A (en) 1979-04-24

Similar Documents

Publication Publication Date Title
JP2023532317A (en) Intermediate for synthesizing camptothecin derivative, method for producing the same, and use thereof
JPS63275582A (en) Production of 1-aminoimidazo(4,5-b)pyridine derivative
CN113292569A (en) Preparation method of JAK inhibitor
Clear et al. Isolation, structure, chemistry, and photochemistry of cis-bis (2, 2′-bipyridyl) carbonylchlororuthenium (II) perchlorate
JPS58189132A (en) Manufacture of butene derivative
JPH02180870A (en) Chiral 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid,precursor compound thereof and preparation of these compound
SU489322A3 (en) Method for preparing substituted 3- (2/4-phenyl-1-piperazinyl / -ethyl) indolines or their salts or their quaternary ammonium salts
JPS5817465B2 (en) Method for producing tetrahydroisoquinoline derivatives
CN112778272B (en) 2, 2' -biazaaryl ring bidentate ligand and preparation method and application thereof
US4251659A (en) Polyfluorohydroxyisopropyl-heterocyclic compounds
US2778832A (en) Reduction of codeinone to codeine
TWI674265B (en) Method for producing flavonoid and its derivative
JPS6396175A (en) Manufacture of 2,4-diamino-3-oxy-6- piperidylpyrimidine
CN115368346B (en) 1, 4-benzodioxane-benzimidazole salt compound and synthesis method and application thereof
CN115215803B (en) Preparation method of 4-halogenated-1- (difluoromethyl) -1H-imidazole
JPH01172389A (en) Large scale synthesis of 12-membered diaza monocyclic compound
CN111995569B (en) Preparation method of cyclin-dependent kinase inhibitor intermediate
JP2522926B2 (en) Method for producing 2'-deoxy-5-trifluoromethyluridine derivative
JP3092633B2 (en) Method for producing 6-substituted-2 (1H) -quinoxalinone compounds
JPS6185344A (en) Triterpene derivative
US3931158A (en) Cis and trans-6-substituted-11-aminoalkylidene-5,6-dihydromorphanthridines
JP4282788B2 (en) Novel diphenylarsines
JPS63284179A (en) Method for producing protoporphyrin disodium salt
JPH04210696A (en) biphenylbisphosphine complex
JPS6130660B2 (en)